Bristol-Myers Squibb Company

ISIN US1101221083 Symbol BMY Industry Drug Manufacturers-General Sector Healthcare
Bristol-Myers Squibb Price
68.56USD 0.25%
1y Low: 51.6
1y High: 67.2
1y Low: 51.6
1y High: 67.2
Bristol-Myers Squibb Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
bms.com
Market Cap
139.6 B USD
Dividend Yield
2.9%
Performance 1y
15.69 %
PER
93.8

Bristol-Myers Squibb Stock Chart

Bristol-Myers Squibb Dividend Chart

Bristol-Myers Squibb Dividend Calendar

Year # Div. Div. Paid Div. Yield Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021 2 0.98 USD 3.6 %
2020 5 2.29 USD 3.8 %
2019 4 1.64 USD 2.7 %
2018 4 1.60 USD 3.3 %
2017 4 1.56 USD 2.8 %
2016 3 1.14 USD 2.2 %
2015 4 1.49 USD 2.5 %
2014 4 1.45 USD 2.9 %
2013 5 1.76 USD 4.0 %
2012 4 1.36 USD 5.3 %
2011 4 1.32 USD 5.1 %
2010 3 0.96 USD 5.0 %
2009 4 1.25 USD 7.0 %
2008 5 1.55 USD 10.4 %
2007 4 1.12 USD 6.8 %
2006 4 1.12 USD 7.4 %
2005 4 1.12 USD 8.8 %
2004 3 0.84 USD 6.1 %
2003 4 1.12 USD 7.7 %
2002 5 1.40 USD 12.2 %
2001 4 1.06 USD 4.4 %
2000 4 0.93 USD 3.1 %
1999 4 0.83 USD 2.8 %
1998 3 0.58 USD 2.1 %
1997 4 0.76 USD 3.9 %
1996 5 0.94 USD 8.2 %
1995 3 0.55 USD 6.5 %
1994 5 0.92 USD 16.5 %
1993 4 0.72 USD 13.4 %
1992 3 0.52 USD 8.9 %
1991 4 0.62 USD 8.6 %
1990 4 0.55 USD 10.1 %
1989 4 0.49 USD 11.5 %
1988 5 0.52 USD 15.3 %
1987 3 0.25 USD 8.3 %
1986 4 0.76 USD 26.4 %
1985 4 0.22 USD 10.7 %
1984 4 0.19 USD 11.8 %
1983 5 0.17 USD 13.6 %
1982 4 0.12 USD 12.1 %
1981 4 0.11 USD 14.4 %
1980 3 0.071 USD 11.0 %

Bristol-Myers Squibb Performance

1 Week
1 Month
2.43 %
6 Months
9.69 %
Year to Date
9.78 %
1 Year
15.69 %
5 Years
2.82 %

Bristol-Myers Squibb Revenue, EBIT, and Income

Bristol-Myers Squibb Margins

Bristol-Myers Squibb Shares Outstanding

Useful Links

Search Twitter: $BMY, #BMY

Bristol-Myers Squibb Company Info

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products in hematology, oncology, cardiovascular, and immunology therapeutic classes. The company's products include Opdivo for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia for adult patients with active RA and prostate-specific antigen, as well as reducing signs and symptoms in pediatric patients with active polyarticular juvenile idiopathic arthritis. It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. In addition, it offers Reyataz, a protease inhibitor to treat human immunodeficiency virus (HIV); Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. It sells products to wholesalers, retail pharmacies, hospitals, government entities, and medical profession. The company has collaboration agreements with Pfizer, Otsuka, Ono, Nektar, GRYT Health, Ubiquigent Limited, Checkmate Pharmaceuticals, and Sensyne Health plc; clinical collaboration with NeoImmuneTech, Inc.; partnership with Astrazeneca Plc; a discovery collaboration with Insitro, Inc.; and collaboration with Schrödinger, Inc. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.

Bristol-Myers Squibb Headquarter

430 East 29th Street, 10016 New York, NY, USA

Bristol-Myers Squibb Price to Earnings Ratio (PE Ratio): 93.8

The current Price to Earnings Ratio of Bristol-Myers Squibb is 93.8.
The PE Ratio is calcluated by dividing the current Bristol-Myers Squibb share price (68.56 USD) by the earnings per share (0.5).

Bristol-Myers Squibb Dividend Yield: 2.9%

The current Dividend Yield of Bristol-Myers Squibb is 2.9%.

Bristol-Myers Squibb Market Cap: 139.6 B USD

The current market cap of Bristol-Myers Squibb is 139.6 B USD.

Bristol-Myers Squibb Stock Price: 68.56 USD

The current stock price of Bristol-Myers Squibb is 68.56 USD.

Bristol-Myers Squibb ISIN: US1101221083

The ISIN (International Securities Identification Number) of Bristol-Myers Squibb is US1101221083.

Bristol-Myers Squibb Ticker Symbol: BMY

The ticker symbol of Bristol-Myers Squibb is BMY.

Bristol-Myers Squibb Address

The address of the Bristol-Myers Squibb HQ is 430 East 29th Street, 10016 New York, NY, USA.